Skip to main content

Advertisement

Table 1 Baseline characteristics of study cohorts and number of first events of CHD and IS

From: Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range

Countries and studies No. (men/women) Age years Mean (range) FPG* (mmol/l) 2hPG* (mmol/l) No. of events (men/women) Maximum (Median) follow-up years
CHD IS
Finland
 East–West Study 125/- 76 (70–90) 5.2 (0.04) 5.4 (0.10) 27/- 24/- 16.8 (10.4)
 FINRISK 1987 859/1006 53 (44–64) 5.1 (0.01) 5.5 (0.03) 142/59 57/46 21.0 (20.8)
 FINRISK 1992 496/747 53 (44–64) 5.2 (0.01) 5.5 (0.03) 32/18 8/11 16.0 (15.9)
 Helsinki Policemen Study 578/- 45 (31–69) 5.7 (0.02) 5.3 (0.05) 141/- 77/- 36.8 (34.5)
 Oulu Study 93/172 55 (55–55) 5.4 (0.03) 6.1 (0.07) 4/4 5/5 17.3 (16.8)
 Vantaa Study 120/168 65 (64–66) 5.2 (0.03) 6.2 (0.07) 16/15 14/9 17.9 (17.3)
Sweden
 Malmö Prevention Project -/821 54 (48–57) 5.5 (0.02) 6.7 (0.04) -/2 -/16 20.0 (14.6)
 MONICA 923/1002 45 (25–74) 5.1 (0.01) 5.3 (0.03) 50/17 12/19 20.6 (16.4)
 ULSAM 549/- 71 (70–73) 5.1 (0.02) 5.5 (0.06) 54/- 38/- 12.4 (10.2)
Total 3743/3916 53 (25–90) 5.2 (0.01) 5.6 (0.01) 466/115 235/106 36.8 (16.4)
  1. *Age-adjusted means (standard error). FPG, fasting plasma glucose; 2hPG, two-hour plasma glucose; CHD, coronary heart disease; IS, ischemic stroke; MONICA, Monitoring of trends and determinants in cardiovascular disease; ULSAM, the Uppsala Longitudinal Study of Adult Men study.